PUNE, India, April 7, 2017 /PRNewswire/ --
The global next-generation sequencing market size is estimated to register a CAGR of 20.5% from 2017 to 2022 to reach $12.45 billion by 2022. SBS technology and Diagnostics application segment is expected to have largest share while North America region expected to command the largest share of the market.
Browse 96 tables and 35 figures, 12 Company profiles spread across 215 pages available at http://www.reportsnreports.com/reports/508000-next-generation-sequencing-ngs-market-by-platforms-hiseq-miseq-hiseq-x-ten-x-five-nextseq500-ion-proton-pgm-ions5-pacbio-sequel-services-targeted-sequencing-de-novo-application-diagnostic-drug-discovery-global-forecasts-to-2021.html .
The global next-generation sequencing market is estimated to register a CAGR of 20.5% from 2017 to 2022 to reach USD 12.45 billion by 2022. Factors such as technological advancements in NGS platforms, increasing applications of NGS, growing partnerships and collaborations, and increasing adoption of NGS among research laboratories and academic institutes are driving the growth of this market. On the other hand, accuracy and standardization concerns in diagnostic testing and the lack of skilled technical personnel are some of the key factors limiting the growth of the market.
On the basis of product and service, the NGS market is categorized into pre-sequencing products and services, NGS platforms, consumables, services for platforms, sequencing services, and bioinformatics. In 2017, the consumables segment is expected to account for the largest share of the market.
On the basis of technology, the global NGS market is segmented into sequencing by synthesis (SBS), ion semiconductor sequencing, single-molecule real-time (SMRT) sequencing, and Nano pore sequencing. In 2017, the SBS technology is expected to account for the largest share of the market, majorly due to the development of new and advanced NGS platforms, the increasing demand for Illumina's systems (including the HiSeq series and MiSeq), and the growing demand for NextSeq and HiSeq X Ten.
Based on applications, the market is categorized into six segments, namely, diagnostics, drug discovery, biomarker discovery, precision medicine, agriculture & animal research, and other application. The diagnostics application segment is expected to account for the major share of the global NGS market owing to the increasing focus of key market players on providing &developing NGS-based diagnostic tests and the growing adoption of NGS-based diagnostic tests related to oncology and infectious diseases.
On the basis of end user, the market is segmented into research centers and academic & government institutes, hospitals & clinics, pharmaceutical & biotechnology companies, and other end users. Among these end users, the hospitals and clinics segment is expected to register the highest CAGR due to the growing number of agreements between companies and hospitals for the development of advanced tests and products catering to the specific needs of hospitals and clinics. For instance, in November 2016, Illumina, Inc. entered into an agreement with Mayo Clinic (U.S.) to install its Base Space Clarity LIMS in Mayo's specific laboratories.
Order a copy of Next-Generation Sequencing (NGS) Market by Product (Hiseq, Miseq, Hiseq X Ten/X Five, NextSeq500, Ion Proton, PGM, Ions5, PacBio RSII), Services (Targeted, RNA, Exome, De Novo), & Application (Diagnostics, Biomarker, Agriculture) - Global Forecasts to 2022 research report at http://www.reportsnreports.com/purchase.aspx?name=508000 .
Geographically, the NGS market is segmented into North America, Europe, Asia-Pacific, and the Rest of the World. North America is expected to command the largest share of the market in 2017, followed by Europe. The market in North America is primarily driven by the technological advancements, availability of commercial solutions for NGS data analysis, and the strong presence of key players in this region. However, Asia-Pacific is expected to register the highest growth rate during the forecast period from 2017 to 2022, due to the improving healthcare infrastructure and favourable government initiatives in this region.
The global NGS market is highly competitive, with a large number of global and local players. In 2016, the global NGS market was dominated by Illumina, Inc. (U.S.), Thermo Fisher Scientific Inc. (U.S.), and Pacific Biosciences of California, Inc. (U.S.), and together held the majority share of the NGS platforms market. New product launches, product enhancements, agreements, and partnerships were the major strategies adopted by market players to achieve growth in the market.
Explore more reports on Public Sector market at http://www.reportsnreports.com/market-research/government/ .
ReportsnReports.com is an online market research reports library of 500,000+ in-depth studies of over 5000 micro markets. Not limited to any one industry, ReportsnReports.com offers research studies on agriculture, energy and power, chemicals, environment, medical devices, healthcare, food and beverages, water, advanced materials and much more.
2nd Floor, Metropole Building
Next to Inox Theatre
Bund Garden Road, Pune - 411001
Connect with Us: